Abstract
Aim:
Phosphodiesterase 4 (PDE4) isozymes are involved in different functions, depending on their patterns of distribution in the brain. The PDE4 subtypes are distributed in different inflammatory cells, and appear to be important regulators of inflammatory processes. In this study we examined the effects of ferulic acid (FA), a plant component with strong anti-oxidant and anti-inflammatory activities, on lipopolysaccharide (LPS)-induced up-regulation of phosphodiesterase 4B (PDE4B) in PC12 cells, which in turn regulated cellular cAMP levels and the cAMP/cAMP response element binding protein (CREB) pathway in the cells.
Methods:
PC12 cells were treated with LPS (1 μg/mL) for 8 h, and the changes of F-actin were detected using laser scanning confocal microscopy. The levels of pro-inflammatory cytokines were measured suing ELISA kits, and PDE4B-specific enzymatic activity was assessed with a PDE4B assay kit. The mRNA levels of PDE4B were analyzed with Q-PCR, and the protein levels of CREB and phosphorylated CREB (pCREB) were determined using immunoblotting. Furthermore, molecular docking was used to identify the interaction between PDE4B2 and FA.
Results:
Treatment of PC12 cells with LPS induced thick bundles of actin filaments appearing in the F-actin cytoskeleton, which were ameliorated by pretreatment with FA (10–40 μmol/L) or with a PDE4B inhibitor rolipram (30 μmol/L). Pretreatment with FA dose-dependently inhibited the LPS-induced production of TNF-α and IL-1β in PC12 cells. Furthermore, pretreatment with FA dose-dependently attenuated the LPS-induced up-regulation of PDE4 activity in PC12 cells. Moreover, pretreatment with FA decreased LPS-induced up-regulation of the PDE4B mRNA, and reversed LPS-induced down-regulation of CREB and pCREB in PC12 cells. The molecular docking results revealed electrostatic and hydrophobic interactions between FA and PDE4B2.
Conclusion:
The beneficial effects of FA in PC12 cells might be conferred through inhibition of LPS-induced up-regulation of PDE4B and stimulation of cAMP/CREB signaling pathway. Therefore, FA may be a potential therapeutic intervention for the treatment of neuroinflammatory diseases such as AD.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Eikelenboom P, Veerhuis R, Scheper W, Rozemuller AJ, van Gool WA, Hoozemans JJ . The significance of neuroinflammation in understanding Alzheimer's disease. J Neural Transm 2006; 113: 1685–95.
Sayyah M, Javad-Pour M, Ghazi-Khansari M . The bacterial endotoxin lipopolysaccharide enhances seizure susceptibility in mice: involvement of proinflammatory factors: nitric oxide and prostaglandins. Neuroscience 2003; 122: 1073–80.
Jaeger LB, Dohgu S, Sultana R, Lynch JL, Owen JB, Erickson MA, et al. Lipopolysaccharide alters the blood-brain barrier transport of amyloid beta protein: a mechanism for inflammation in the progression of Alzheimer's disease. Brain Behav Immun 2009; 23: 507–17.
Nakanishi N, Guroff G . Nerve growth factor-induced increase in the cell-free phosphorylation of a nuclear protein in PC12 cells. J Biol Chem 1985; 260: 7791–9.
Isoda H, Talorete TP, Kimura M, Maekawa T, Inamori Y, Nakajima N, et al. Phytoestrogens genistein and daidzin enhance the acetylcholinesterase activity of the rat pheochromocytoma cell line PC12 by binding to the estrogen receptor. Cytotechnology 2002; 40: 117–23.
Guo J, Li F, Wu Q, Gong Q, Lu Y, Shi J . Protective effects of icariin on brain dysfunction induced by lipopolysaccharide in rats. Phytomedicine 2010; 17: 950–5.
Min SS, Quan HY, Ma J, Han JS, Jeon BH, Seol GH . Chronic brain inflammation impairs two forms of long-term potentiation in the rat hippocampal CA1 area. Neurosci Lett 2009; 456: 20–4.
Breder CD, Saper CB . Expression of inducible cyclooxygenase mRNA in the mouse brain after systemic administration of bacterial lipopolysaccharide. Brain Res 1996; 713: 64–9.
Breder CD, Hazuka C, Ghayur T, Klug C, Huginin M, Yasuda K, et al. Regional induction of tumor necrosis factor alpha expression in the mouse brain after systemic lipopolysaccharide administration. Proc Natl Acad Sci U S A 1994; 91: 11393–7.
Reyes-Irisarri E, Perez-Torres S, Miro X, Martinez E, Puigdomenech P, Palacios JM, et al. Differential distribution of PDE4B splice variant mRNAs in rat brain and the effects of systemic administration of LPS in their expression. Synapse 2008; 62: 74–9.
Jin SL, Conti M . Induction of the cyclic nucleotide phosphodiesterase PDE4B is essential for LPS-activated TNF-alpha responses. Proc Natl Acad Sci U S A 2002; 99: 7628–33.
Teixeira MM, Gristwood RW, Cooper N, Hellewell PG . Phosphodiesterase (PDE)4 inhibitors: anti-inflammatory drugs of the future? Trends Pharmacol Sci 1997; 18: 164–71.
Wang P, Wu P, Ohleth KM, Egan RW, Billah MM . Phosphodiesterase 4B2 is the predominant phosphodiesterase species and undergoes differential regulation of gene expression in human monocytes and neutrophils. Mol Pharmacol 1999; 56: 170–4.
Xu Y, Zhang HT, O'Donnell JM . Phosphodiesterases in the central nervous system: implications in mood and cognitive disorders. Handb Exp Pharmacol 2011; 204: 447–85.
Cherry JA, Davis RL . Cyclic AMP phosphodiesterases are localized in regions of the mouse brain associated with reinforcement, movement, and affect. J Comp Neurol 1999; 407: 287–301.
Johansson EM, Reyes-Irisarri E, Mengod G . Comparison of cAMP-specific phosphodiesterase mRNAs distribution in mouse and rat brain. Neurosci Lett 2012; 525: 1–6.
Perez-Torres S, Miro X, Palacios JM, Cortes R, Puigdomenech P, Mengod G . Phosphodiesterase type 4 isozymes expression in human brain examined by in situ hybridization histochemistry and (3H] rolipram binding autoradiography. Comparison with monkey and rat brain. J Chem Neuroanat 2000; 20: 349–74.
Ahmed T, Frey JU . Expression of the specific type IV phosphodiesterase gene PDE4B3 during different phases of long-term potentiation in single hippocampal slices of rats in vitro. Neuroscience 2003; 117: 627–38.
Ahmed T, Frey JU . Phosphodiesterase 4B (PDE4B) and cAMP-level regulation within different tissue fractions of rat hippocampal slices during long-term potentiation in vitro. Brain Res 2005; 1041: 212–22.
Ahmed T, Frey S, Frey JU . Regulation of the phosphodiesterase PDE4B3-isotype during long-term potentiation in the area dentata in vivo. Neuroscience 2004; 124: 857–67.
Murakami A, Kadota M, Takahashi D, Taniguchi H, Nomura E, Hosoda A, et al. Suppressive effects of novel ferulic acid derivatives on cellular responses induced by phorbol ester, and by combined lipopolysaccharide and interferon-gamma. Cancer Lett 2000; 157: 77–85.
Hosoda A, Ozaki Y, Kashiwada A, Mutoh M, Wakabayashi K, Mizuno K, et al. Syntheses of ferulic acid derivatives and their suppressive effects on cyclooxygenase-2 promoter activity. Bioorg Med Chem 2002; 10: 1189–96.
Ou L, Kong LY, Zhang XM, Niwa M . Oxidation of ferulic acid by Momordica charantia peroxidase and related anti-inflammation activity changes. Biol Pharm Bull 2003; 26: 1511–6.
Srinivasan M, Sudheer AR, Menon VP . Ferulic acid: therapeutic potential through its antioxidant property. J Clin Biochem Nutr 2007; 40: 92–100.
Lin TY, Lu CW, Huang SK, Wang SJ . Ferulic acid suppresses glutamate release through inhibition of voltage-dependent calcium entry in rat cerebrocortical nerve terminals. J Med Food 2013; 16: 112–9.
Mancuso C, Scapagini G, Curro D, Giuffrida Stella AM, De Marco C, Butterfield DA, et al. Mitochondrial dysfunction, free radical generation and cellular stress response in neurodegenerative disorders. Fronti Biosci 2007; 12: 1107–23.
Dong GC, Kuan CY, Subramaniam S, Zhao JY, Sivasubramaniam S, Chang HY, et al. A potent inhibition of oxidative stress induced gene expression in neural cells by sustained ferulic acid release from chitosan based hydrogel. Mater Sci EngC Materi Biol Appl 2015; 49: 691–9.
Cheng CY, Su SY, Tang NY, Ho TY, Chiang SY, Hsieh CL . Ferulic acid provides neuroprotection against oxidative stress-related apoptosis after cerebral ischemia/reperfusion injury by inhibiting ICAM-1 mRNA expression in rats. Brain Res 2008; 1209: 136–50.
Kawabata K, Yamamoto T, Hara A, Shimizu M, Yamada Y, Matsunaga K, et al. Modifying effects of ferulic acid on azoxymethane-induced colon carcinogenesis in F344 rats. Cancer Lett 2000; 157: 15–21.
Balasubashini MS, Rukkumani R, Viswanathan P, Menon VP . Ferulic acid alleviates lipid peroxidation in diabetic rats. Phytother Res 2004; 18: 310–4.
Sultana R, Ravagna A, Mohmmad-Abdul H, Calabrese V, Butterfield DA . Ferulic acid ethyl ester protects neurons against amyloid beta- peptide(1-42)-induced oxidative stress and neurotoxicity: relationship to antioxidant activity. J Neurochem 2005; 92: 749–58.
Yogeeta SK, Gnanapragasam A, Kumar SS, Subhashini R, Sathivel A, Devaki T . Synergistic interactions of ferulic acid with ascorbic acid: its cardioprotective role during isoproterenol induced myocardial infarction in rats. Mol Cell Biochem 2006; 283: 139–46.
Huang H, Ma ZC, Wang YG, Hong Q, Tan HL, Xiao CR, et al. Ferulic acid alleviates Abeta25-35- and lipopolysaccharide-induced PC12 cellular damage: a potential role in Alzheimer's disease by PDE inhibition. Int J Clin Pharmacol Ther 2015; 53: 828–37.
Yabe T, Hirahara H, Harada N, Ito N, Nagai T, Sanagi T, et al. Ferulic acid induces neural progenitor cell proliferation in vitro and in vivo. Neuroscience 2010; 165: 515–24.
Gobejishvili L, Avila DV, Barker DF, Ghare S, Henderson D, Brock GN, et al. S-adenosylmethionine decreases lipopolysaccharide-induced phosphodiesterase 4B2 and attenuates tumor necrosis factor expression via cAMP/protein kinase A pathway. J Pharmacol Exp Ther 2011; 337: 433–43.
Xu RX, Rocque WJ, Lambert MH, Vanderwall DE, Luther MA, Nolte RT . Crystal structures of the catalytic domain of phosphodiesterase 4B complexed with AMP, 8-Br-AMP, and rolipram. J Mol Biol 2004; 337: 355–65.
Li S, Duance VC, Blain EJ . F-actin cytoskeletal organization in intervertebral disc health and disease. Biochem Soc Trans 2007; 35: 683–5.
Niemand C, Nimmesgern A, Haan S, Fischer P, Schaper F, Rossaint R, et al. Activation of STAT3 by IL-6 and IL-10 in primary human macrophages is differentially modulated by suppressor of cytokine signaling 3. J Immunol 2003; 170: 3263–72.
Akiyama H, Barger S, Barnum S, Bradt B, Bauer J, Cole GM, et al. Inflammation and Alzheimer's disease. Neurobio Aging 2000; 21: 383–421.
Chauhan V, Chauhan A . Oxidative stress in Alzheimer's disease. Pathophysiology 2006; 13: 195–208.
Cheng CY, Ho TY, Lee EJ, Su SY, Tang NY, Hsieh CL . Ferulic acid reduces cerebral infarct through its antioxidative and anti-inflammatory effects following transient focal cerebral ischemia in rats. Am J Chin Med 2008; 36: 1105–19.
Navarrete S, Alarcon M, Palomo I . Aqueous extract of tomato (Solanum lycopersicum L) and ferulic acid reduce the expression of TNF-alpha and IL-1beta in LPS-activated macrophages. Molecules 2015; 20: 15319–29.
Huang F, Deng HM, Zhu MM, Xiao F, Yang L, Zhang ZJ, et al. Inhibitory effect of ferulic acid on inflammatory response in microglia induced by lipopolysaccharides. Dongwuxue Yanjiu 2011; 32: 311–6.
Ghosh M, Garcia-Castillo D, Aguirre V, Golshani R, Atkins CM, Bramlett HM, et al. Proinflammatory cytokine regulation of cyclic AMP-phosphodiesterase 4 signaling in microglia in vitro and following CNS injury. Glia 2012; 60: 1839–59.
Baumer W, Hoppmann J, Rundfeldt C, Kietzmann M . Highly selective phosphodiesterase 4 inhibitors for the treatment of allergic skin diseases and psoriasis. Inflamm Allergy Drug Targets 2007; 6: 17–26.
Souness JE, Aldous D, Sargent C . Immunosuppressive and anti-inflammatory effects of cyclic AMP phosphodiesterase (PDE) type 4 inhibitors. Immunopharmacology 2000; 47: 127–62.
Conti M, Richter W, Mehats C, Livera G, Park JY, Jin C . Cyclic AMP-specific PDE4 phosphodiesterases as critical components of cyclic AMP signaling. J Biol Chem 2003; 278: 5493–6.
D'Sa C, Eisch AJ, Bolger GB, Duman RS . Differential expression and regulation of the cAMP-selective phosphodiesterase type 4A splice variants in rat brain by chronic antidepressant administration. Eur J Neurosci 2005; 22: 1463–75.
McPhee I, Cochran S, Houslay MD . The novel long PDE4A10 cyclic AMP phosphodiesterase shows a pattern of expression within brain that is distinct from the long PDE4A5 and short PDE4A1 isoforms. Cell Signal 2001; 13: 911–8.
Miro X, Perez-Torres S, Puigdomenech P, Palacios JM, Mengod G . Differential distribution of PDE4D splice variant mRNAs in rat brain suggests association with specific pathways and presynaptical localization. Synapse 2002; 45: 259–69.
Zhang HT . Cyclic AMP-specific phosphodiesterase-4 as a target for the development of antidepressant drugs. Curr Pharm Des 2009; 15: 1688–98.
Houslay MD, Schafer P, Zhang KY . Keynote review: phosphodiesterase-4 as a therapeutic target. Drug Discov Today 2005; 10: 1503–19.
O'Donnell JM, Zhang HT . Antidepressant effects of inhibitors of cAMP phosphodiesterase (PDE4). Trends Pharmacol Sci 2004; 25: 158–63.
Titus SA, Li X, Southall N, Lu J, Inglese J, Brasch M, et al. A cell-based PDE4 assay in 1536-well plate format for high-throughput screening. J Biomol Screen 2008; 13: 609–18.
Millar JK, Mackie S, Clapcote SJ, Murdoch H, Pickard BS, Christie S, et al. Disrupted in schizophrenia 1 and phosphodiesterase 4B: towards an understanding of psychiatric illness. J Physiol 2007; 584: 401–5.
Mori T, Koyama N, Guillot-Sestier MV, Tan J, Town T . Ferulic acid is a nutraceutical beta-secretase modulator that improves behavioral impairment and alzheimer-like pathology in transgenic mice. PLoS One 2013; 8: e55774.
Nakajima T, Uchida C, Anderson SF, Parvin JD, Montminy M . Analysis of a cAMP-responsive activator reveals a two-component mechanism for transcriptional induction via signal-dependent factors. Genes Dev 1997; 11: 738–47.
Kida S, Josselyn SA, Pena de Ortiz S, Kogan JH, Chevere I, Masushige S, et al. CREB required for the stability of new and reactivated fear memories. Nat Neurosci 2002; 5: 348–55.
Josselyn SA, Kida S, Silva AJ . Inducible repression of CREB function disrupts amygdala-dependent memory. Neurobiol Learn Mem 2004; 82: 159–63.
Pittenger C, Huang YY, Paletzki RF, Bourtchouladze R, Scanlin H, Vronskaya S, et al. Reversible inhibition of CREB/ATF transcription factors in region CA1 of the dorsal hippocampus disrupts hippocampus-dependent spatial memory. Neuron 2002; 34: 447–62.
Restivo L, Tafi E, Ammassari-Teule M, Marie H . Viral-mediated expression of a constitutively active form of CREB in hippocampal neurons increases memory. Hippocampus 2009; 19: 228–34.
Ahmed T, Frey JU . Plasticity-specific phosphorylation of CaMKII, MAP-kinases and CREB during late-LTP in rat hippocampal slices in vitro. Neuropharmacology 2005; 49: 477–92.
Blokland A, Schreiber R, Prickaerts J . Improving memory: a role for phosphodiesterases. Curr Pharm Des 2006; 12: 2511–23.
Coskran TM, Morton D, Menniti FS, Adamowicz WO, Kleiman RJ, Ryan AM, et al. Immunohistochemical localization of phosphodiesterase 10A in multiple mammalian species. J Histochem Cytochem 2006; 54: 1205–13.
Han JH, Kushner SA, Yiu AP, Cole CJ, Matynia A, Brown RA, et al. Neuronal competition and selection during memory formation. Science 2007; 316: 457–60.
Jasnow AM, Shi C, Israel JE, Davis M, Huhman KL . Memory of social defeat is facilitated by cAMP response element-binding protein overexpression in the amygdala. Behav Neurosci 2005; 119: 1125–30.
Naganuma K, Omura A, Maekawara N, Saitoh M, Ohkawa N, Kubota T, et al. Discovery of selective PDE4B inhibitors. Bio Med Chem Lett 2009; 19: 3174–6.
Wallace TL, Stellitano KE, Neve RL, Duman RS . Effects of cyclic adenosine monophosphate response element binding protein overexpression in the basolateral amygdala on behavioral models of depression and anxiety. Biol Psychiatry 2004; 56: 151–60.
Maurice DH, Ke H, Ahmad F, Wang Y, Chung J, Manganiello VC . Advances in targeting cyclic nucleotide phosphodiesterases. Nat Rev Drug Discov 2014; 13: 290–314.
Zidek Z . Adenosine - cyclic AMP pathways and cytokine expression. Eur Cytokine Netw 1999; 10: 319–28.
Gobejishvili L, Barve S, Joshi-Barve S, Uriarte S, Song Z, McClain C . Chronic ethanol-mediated decrease in cAMP primes macrophages to enhanced LPS-inducible NF-kappaB activity and TNF expression: relevance to alcoholic liver disease. Am J Physiol Gastrointest Liver Physiol 2006; 291: G681–8.
Acknowledgements
This work was supported by the National Natural Science Foundation of China (No 81130067 and 81202936).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Huang, H., Hong, Q., Tan, Hl. et al. Ferulic acid prevents LPS-induced up-regulation of PDE4B and stimulates the cAMP/CREB signaling pathway in PC12 cells. Acta Pharmacol Sin 37, 1543–1554 (2016). https://doi.org/10.1038/aps.2016.88
Received:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/aps.2016.88
Keywords
This article is cited by
-
Neuroprotective Effect of Piclamilast-Induced Post-Ischemia Pharmacological Treatment in Mice
Neurochemical Research (2022)
